Insights into mechanisms underlying the gut and airways modulatory effects of Swertia chirata - PubMed
Insights into mechanisms underlying the gut and airways modulatory effects of Swertia chirata
Arif-ullah Khan et al. J Nat Med. 2012 Jan.
Abstract
Swertia chirata is used in folk medicine for the treatment of constipation, colic, diarrhea, and asthma. This study was carried out in order to provide a pharmacological basis for its medicinal use in gastrointestinal and respiratory disorders. Crude extract of Swertia chirata (Sc.Cr) and its fractions were studied using rabbit isolated tissue preparations. In jejunum, Sc.Cr, which tested positive for alkaloids, flavonoids, saponins, tannins, and terpenes, caused stimulation at concentrations of 0.01-1.0 mg/mL, followed by a relaxant effect at higher concentrations. In the presence of atropine, the contractile effect was blocked and only relaxation occurred. Sc.Cr inhibited high K(+) (80 mM)-induced contractions at 0.01-10 mg/mL and shifted Ca(2+) concentration-response curves to the right, similar to that caused by verapamil. In trachea, Sc.Cr relaxed the carbachol (1 μM) and high K(+)-induced contractions, in a pattern similar to that of verapamil. Bioassay directed fractionation revealed the separation of spasmogenic and spasmolytic components in aqueous and organic fractions, respectively. The chloroform fraction exhibited a concentration-dependent (0.1-3.0 mg/mL) bronchodilator effect. These results indicate that Swertia chirata exhibits gut excitatory and inhibitory effects, mediated through cholinergic and Ca(2+) antagonist mechanisms, respectively, as well as bronchodilatation, via Ca(2+) channel blockade. Thus, this study provides a sound mechanistic background for the therapeutic application of Swertia chirata in gut motility disorders, such as constipation, colic, and diarrhea, and airways hyperactivity disease, such as asthma.
Similar articles
-
Hussain M, Waqas HM, Raza SM, Farooq U, Ahmed MM, Majeed A. Hussain M, et al. J Ethnopharmacol. 2016 Dec 4;193:474-480. doi: 10.1016/j.jep.2016.09.028. Epub 2016 Sep 30. J Ethnopharmacol. 2016. PMID: 27693774
-
Khan AU, Gilani AH. Khan AU, et al. J Ethnopharmacol. 2009 Dec 10;126(3):480-6. doi: 10.1016/j.jep.2009.09.010. Epub 2009 Sep 12. J Ethnopharmacol. 2009. PMID: 19751814
-
Gilani AH, Khan AU, Raoof M, Ghayur MN, Siddiqui BS, Vohra W, Begum S. Gilani AH, et al. Fundam Clin Pharmacol. 2008 Feb;22(1):87-99. doi: 10.1111/j.1472-8206.2007.00561.x. Fundam Clin Pharmacol. 2008. PMID: 18251725
Cited by
-
Ahmad S, Zahiruddin S, Parveen B, Basist P, Parveen A, Gaurav, Parveen R, Ahmad M. Ahmad S, et al. Front Pharmacol. 2021 Mar 2;11:578970. doi: 10.3389/fphar.2020.578970. eCollection 2020. Front Pharmacol. 2021. PMID: 33737875 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous